NY-UBS/BLOOMBERG
UBS and Bloomberg announce the launch of "Girls Take Finance," a global initiative that expands the 2019 "Girls Take" events to 12 cities worldwide. "Girls Take Finance" aims to inspire the next-generation of leaders by providing young women, aged 14-18, with insight into the financial services industry and career opportunities in business, finance and technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200227005522/en/
In 2020, UBS and Bloomberg will expand "Girls Take Finance" to major cities across the globe, including Frankfurt, Jakarta, Johannesburg, London, San Francisco, São Paulo, Sydney, and Zurich.
"As someone who started his career in financial services as an apprentice at age 15, I know first-hand how important encouragement is to making career choices," said UBS Group CEO Sergio P. Ermotti. "That's why I'm so delighted to expand the program this year. Together with Bloomberg, we can inspire hundreds of young women who otherwise might not have seriously considered pursuing careers in areas like finance, banking and technology."
As with the previous "Girls Take" events, UBS and Bloomberg are partnering with local non-profits in each city to host on-site events at some of the world's most iconic locations in business and finance. The full-day programming will include workshops focused on career growth and networking skills, panel discussions with industry experts, and motivational talks with volunteers about the variety of careers in financial services.
“Businesses that want to attract tomorrow’s brightest talent must do more to make careers in their industry accessible to more diverse groups at an earlier age,” said Peter T. Grauer, Chairman of Bloomberg LP and Founding Chairman of the U.S. 30% Club. “We’re glad to participate in 'Girls Take Finance' and are excited to expand the program’s footprint in its second year so that more young women can see a future for themselves in our industry, which is eager for their talent and perspective.”
The initiative builds on the success of the inaugural "Girls Take" events, which began March 2019 as "Girls Take Wall Street " in New York City, where UBS, Bloomberg and State Street Global Advisors convened more than 100 high school girls for a day of educational career mentorship. The day ended with the girls ringing The Closing Bell® at the New York Stock Exchange to commemorate the start of Women's History Month.
In October 2019, UBS and Bloomberg took "Girls Take Wall Street" to India, hosting "Girls Take Dalal Street" in Mumbai and "Girls Take GIFT City" in Ahmedabad . Nearly 150 young women from colleges across Mumbai, Pune and Ahmedabad participated in the mentoring events. Students also had the opportunity to ring the Closing Bell at the Bombay Stock Exchange and visited the India International Exchange (INX), India’s first international stock exchange.
Additionally, UBS and Bloomberg have standalone initiatives that focus on helping young people advance their education and future careers.
UBS is committed to taking a leading role in driving change that matters in the world. Through strategic financial commitments and targeted employee volunteering to advance education, the firm is dedicated to empowering the next generation of young people. This is demonstrated through efforts across the firm's Community Affairs programs, including The Bridge Academy in the UK, Keys To Your Future: College and Career Readiness in the US, YES (Young Enterprise Switzerland) in Switzerland and UBS Community Academies in APAC. A pioneer in social finance, the UBS Optimus Foundation takes a leading role in driving impactful philanthropy that delivers breakthrough solutions to social and environmental issues. UBS is also a founding partner of #TOGETHERBAND , a campaign with the Bottletop Foundation that aims to promote the United Nations Sustainable Development Goals (SDGs), to achieve a more sustainable world by 2030. The #TOGETHERBAND campaign will launch SDG5, Gender Equality and Women's Empowerment in March to coincide with the initiative.
Bloomberg Startup, the company’s global philanthropic education engagement program, supports young women around the world by providing access to mentors, internships, and career-readiness workshops that expose students to diverse and influential women. Read more about how Bloomberg is advancing women: https://www.bloomberg.com/women .
Confirmed 2020 "Girls Take Finance" Non-Profit Partners:
City & Date: |
Non-Profit Partner: |
|||
London, UK – March 2 |
||||
San Francisco, US – March 4 |
||||
New York, US – March 6 |
||||
Zurich, CH – March 6 |
||||
Johannesburg, ZA – March 6 |
||||
Sydney, AU – March 12 |
ABCN and CareerTrackers |
|||
São Paulo, BR – March 17 |
||||
Frankfurt, DE – March 20 |
||||
Bangkok, TH – August |
Later in 2020, UBS and Bloomberg will also bring Girls Take Finance to Indonesia and India, hosting events in Jakarta, Mumbai and GIFT City.
Notes to Editors
About UBS
UBS provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as private clients in Switzerland. UBS's strategy is centered on our leading global wealth management business and our premier universal bank in Switzerland, enhanced by Asset Management and the Investment Bank. The bank focuses on businesses that have a strong competitive position in their targeted markets, are capital efficient, and have an attractive long-term structural growth or profitability outlook.
About Bloomberg
Bloomberg, the global business and financial information and news leader, gives influential decision makers a critical edge by connecting them to a dynamic network of information, people and ideas. The company’s strength – delivering data, news and analytics through innovative technology, quickly and accurately – is at the core of the Bloomberg Terminal. Bloomberg’s enterprise solutions build on the company’s core strength: leveraging technology to allow customers to access, integrate, distribute and manage data and information across organizations more efficiently and effectively. For more information, visit www.bloomberg.com or request a demo .
© UBS 2020. All rights reserved. The key symbol and UBS are among the registered and unregistered trademarks of UBS.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200227005522/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom